Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Roberts

Showing results (131-140 of 252) with videos related to

Pageof 26
Sort By:
Bone|November 7, 2022
The efficacy and safety of burosumab in two patients with cutaneous skeletal hypophosphatemia syndromeJeffrey Sugarman, Ann Maruri, Dale J Hamilton, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 19, 2006
Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL StudySusan LaRusse Eckert, Heather Katzen, J Scott Roberts, et al.
Journal of the American Medical Directors Association|June 1, 2019
Dementia Care Across a Tertiary Care Health System: What Exists Now and What Needs to ChangeAmanda Leggett, Cathleen Connell, Leslie Dubin, et al.
Glomerular Diseases|October 30, 2023
Assessment of the Needs of Nephrology Divisions to Implement Return of Clinically Significant Research Genetic Results: A Survey of Nephrotic Syndrome Study Network (NEPTUNE) InvestigatorsJennifer E Fishbein, Loryn Wilson Dass, Chrysta Lienczewski, et al.
Journal of Alzheimer'S Disease Reports|April 3, 2026
Qualitative insights into participant and care partner perspectives on research-based Alzheimer's disease biomarker testing and disclosureAnnalise Rahman-Filipiak, Mary Lesniak, Alicia Burgei, et al.
Public Health Genomics|September 11, 2025
Employee Perspectives on Genetic Testing in the Workplace: Results from a National SurveyJ Scott Roberts, Wendy R Uhlmann, Drew Blasco, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 23, 2016
Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) StudyDeanna Alexis Carere, Tyler J VanderWeele, Jason L Vassy, et al.
Genome Medicine|August 14, 2015
Explaining, not just predicting, drives interest in personal genomicsSusanne F Meisel, Deanna Alexis Carere, Jane Wardle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 18, 2008
Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's diseaseMichael R Cassidy, J Scott Roberts, Thomas D Bird, et al.
Annals of Internal Medicine|March 2, 2016
Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic TestingCathelijne H van der Wouden, Deanna Alexis Carere, Anke H Maitland-van der Zee, et al.
Pageof 26

Showing results (131-140 of 252) with videos related to

Sort By:
Pageof 26
Bone|November 7, 2022
The efficacy and safety of burosumab in two patients with cutaneous skeletal hypophosphatemia syndromeJeffrey Sugarman, Ann Maruri, Dale J Hamilton, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 19, 2006
Recall of disclosed apolipoprotein E genotype and lifetime risk estimate for Alzheimer's disease: the REVEAL StudySusan LaRusse Eckert, Heather Katzen, J Scott Roberts, et al.
Journal of the American Medical Directors Association|June 1, 2019
Dementia Care Across a Tertiary Care Health System: What Exists Now and What Needs to ChangeAmanda Leggett, Cathleen Connell, Leslie Dubin, et al.
Glomerular Diseases|October 30, 2023
Assessment of the Needs of Nephrology Divisions to Implement Return of Clinically Significant Research Genetic Results: A Survey of Nephrotic Syndrome Study Network (NEPTUNE) InvestigatorsJennifer E Fishbein, Loryn Wilson Dass, Chrysta Lienczewski, et al.
Journal of Alzheimer'S Disease Reports|April 3, 2026
Qualitative insights into participant and care partner perspectives on research-based Alzheimer's disease biomarker testing and disclosureAnnalise Rahman-Filipiak, Mary Lesniak, Alicia Burgei, et al.
Public Health Genomics|September 11, 2025
Employee Perspectives on Genetic Testing in the Workplace: Results from a National SurveyJ Scott Roberts, Wendy R Uhlmann, Drew Blasco, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 23, 2016
Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) StudyDeanna Alexis Carere, Tyler J VanderWeele, Jason L Vassy, et al.
Genome Medicine|August 14, 2015
Explaining, not just predicting, drives interest in personal genomicsSusanne F Meisel, Deanna Alexis Carere, Jane Wardle, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 18, 2008
Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's diseaseMichael R Cassidy, J Scott Roberts, Thomas D Bird, et al.
Annals of Internal Medicine|March 2, 2016
Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic TestingCathelijne H van der Wouden, Deanna Alexis Carere, Anke H Maitland-van der Zee, et al.
Pageof 26